Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Multiple recent lines of evidence have underscored the potential role of glycogen synthase kinase-3 (GSK3) as a common molecular signal integrator and therapeutic target for different classes of psychiatric drugs (Figure 1). GSK3α and GSK3β are two closely related serine/threonine kinases originally associated with the regulation of glycogen synthesis in response to insulin (Embi et al., 1980). These constitutively active kinases are regulated negatively through the phosphorylation of single serine residues, Ser21 (GSK3α) and Ser9 (GSK3β), of their regulatory amino-terminal domain (Frame and Cohen, 2001). The protein kinase Akt/PKB has been shown to inhibit both GSK3 isoforms in response to insulin and insulin growth factors (Cross et al., 1995). However, other protein kinases such as PKA and PKC can also regulate GSK3 in different cellular systems (Frame and Cohen, 2001). Apart from its function in glycogenesis, GSK3 plays a role in a host of physiological processes including neurodevelopment, cell proliferation and apoptosis. Moreover, dysregulation of GSK3 function is involved in tumour proliferation as well as in the formation of neurofibrillary tangles in Alzheimer's disease (Woodgett, 2003).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia
Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300 · cited 4×
“Two 5-HT receptors appear to play important and antagonistic roles in regulating GSK3b, stimulation of 5-HT1A receptors leading to kinase inhibition while stimulation of 5-HT2A receptors has the opposite effect (Li et al., 2004).”
BackgroundMethodInfluential
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Self-citationGSK3 signalling in neural development
Hur, E.-M., & Zhou, F.-Q. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2870 · Cited by 838
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522
Self-citationThe Akt–GSK-3 signaling cascade in the actions of dopamine
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.006 · Cited by 419
Self-citationRole of GSK3β in behavioral abnormalities induced by serotonin deficiency
Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368
Self-citation
Metadata
- Authors
- Beaulieu, J.-M.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06-21
- Volume
- 10
- Issue
- 01
- Pages
- 3
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2115991930
- Cited by
- 71
- References
- 4
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. https://app.cochat.ai/papers/10.1017/s1461145706006857
- The paper
- Beaulieu, J.-M. (2007). Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145706006857
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.